ArticleInfection and immunity1996
Serological analysis of antigenic heterogeneity of Giardia lamblia variant surface proteins.
Article in Infection and immunity, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Review
- Disease Biomarkers of Giardiasis.Journal of parasitology research · 2022Review
- Comparative proteomics of threeParasitology · 2020Article
- Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens.Clinical and vaccine immunology : CVI · 2010Article
- Experimental infections of neonatal mice with cysts of Giardia lamblia clone GS/M-83-H7 are associated with an antigenic reset of the parasite.Infection and immunity · 2004Article
- Interleukin-6-deficient mice are highly susceptible to Giardia lamblia infection but exhibit normal intestinal immunoglobulin A responses against the parasite.Infection and immunity · 2003Article
- Role of interleukin-6 in the control of acute and chronic Giardia lamblia infections in mice.Infection and immunity · 2003Article
- Immune response to Giardia duodenalis.Clinical microbiology reviews · 2000Review
- Influence of antibodies in mother's milk on antigenic variation of Giardia lamblia in the murine mother-offspring model of infection.Infection and immunity · 1998Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neonatal ZU.ICR mice were infected with trophozoites of Giardia lamblia clone GS/M-83-H7 expressing the variant surface protein (VSP) H7 and were subsequently investigated for their serum antibody response directed against VSPH7. Recombinant polypeptides, representing overlapping segments of VSPH7, and native Giardia proteins were used as antigenic reagents to examine the antigenic substructure of VSPH7 and the extent of antigenic variation in vivo. VSPH7 proved to be the predominant antigen of the parasite with respect to serum antibody reactivity. The data indicated that VSPH7 basically consists of two antigenically distinct parts: (i) a unique, variant-specific 314-amino-acid N-terminal region which elicits a low antibody response preferentially detectable during the early phase of the infection and (ii) a 171-amino-acid C-terminal region which elicits a high antibody response during the later phase or after resolution of the infection. The epitopes of the C-terminal region appear to be shared by other, as yet uncharacterized, variant antigens. The highly conserved 34-amino-acid stretch at the extreme C terminus of VSPH7 exhibited no immunoreactivity to any of the sera tested. Further investigations indicated that antigenic variation of the intestinal parasite population was associated with a diversification into at least six to nine new antigen types. These variant antigens were extremely heterogeneous in size ranging from approximately 50 to 115 kDa. None of these proteins shared antigenic epitopes with the 314-amino-acid N-terminal portion, but several of them cross-reacted with antibodies specific to the 171-amino-acid C-terminal portion of the VSP from the original inoculum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.